Indian injectables maker KriGen to build $7M plant in North Carolina

B. Braun IV bags
KriGen Pharmaceuticals, an India-based injectables maker, unveiled plans to build a $7 million facility in Lillinton, North Carolina. (B.Braun)

KriGen Pharmaceuticals, an India-based injectables maker, unveiled plans to build a $7 million facility in Lillington, North Carolina.

The 55,000-square-foot facility will produce medical IV bags and injectables and create about 100 jobs. According to the company’s website, KriGen products currently include dextrose and sodium chloride IV bags.

“The vision of KriGen Pharmaceuticals is to improve the quality of human lives by providing affordable pharmaceutical formulations based on innovation and technology,” Dhruvkumar Patel, the company’s chief financial officer, said in a statement reported by WRAL TechWire.

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

The company is expected to receive a $200,000 grant from the One North Carolina Fund as part of an effort to attract KriGen to the state.

The company did not say when the project is expected to be completed.

A saline shortage due to production issues with a number of manufacturers since 2014 was exacerbated when hurricanes Irma and Maria wreaked havoc on pharma plants in Puerto Rico.

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.